
Kadans buys Oxford Biomedica’s Windrush Court facility for £60m
Published on November 14, 2022
Kadans Science Partner has acquired Oxford Biomedica’s Windrush Court in Oxford for £60m in a sale-and-leaseback transaction.

Kadans Science Partner has acquired Oxford Biomedica’s Windrush Court in Oxford for £60m in a sale-and-leaseback transaction.